Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycin

Small molecule inhibitors, such as imatinib, are effective therapies for tyrosine kinase fusions BCR-ABL–TEL-PDGFβR–mediated human leukemias, but resistance may develop. The unique fusion junctions of these molecules are attractive candidates for molecularly targeted therapeutic intervention using R...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chen, Jing, Wall, Nathan R., Kocher, Kerry, Duclos, Nicole, Fabbro, Doriano, Neuberg, Donna, Griffin, James D., Shi, Yang, Gilliland, D. Gary
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2004
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC420507/
https://ncbi.nlm.nih.gov/pubmed/15199413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI200420673
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars